Home / Resource Library / Multicenter development of a PET‑based risk assessment tool for product‑specific outcome prediction in large B‑cell lymphoma patients undergoing CAR T‑cell therapy
Multicenter development of a PET‑based risk assessment tool for product‑specific outcome prediction in large B‑cell lymphoma patients undergoing CAR T‑cell therapy